SlideShare a Scribd company logo
1 of 37
Anesthesia &
Peripheral Vascular
Disease
Justin Scott Fulkerson
ACNP-BC, sRNA
Outline
• Anatomy Review
• Peripheral Arterial Diseases (major)
• Peripheral Venous Diseases (secondary)
• Systemic Vasculitis (time permitting)
ANATOMY REVIEW
QuickReminders
• Arteries
Large
Medium
Small
• Arterioles
Higher muscle ratio and
can completely occlude
lumen
2/3 of total systemic
resistance
• Capillaries
One-cell thick
Highest cross-sectional
area
Exchange nutrients
• Venules
Collect blood
• Veins
Blood reservoir (64%)
8x more distensible
Low pressure
Thin walls (less muscle)
BloodVessels
Tunica intima (Endothelium, basement membrane); tunica media; tunica externa
PERIPHERAL ARTERIAL DISEASE
Bottom Line Up Front
• Also known as peripheral artery disease, peripheral arterial disease,
peripheral vascular disease, peripheral arterial insufficiency, chronic
arterial insufficiency, PAD, PVD
• Miller: Aneurysmal or occlusive arterial disease of the extremities,
visceral organs, head, neck, and brain
• Defined as compromised blood flow to the extremities
• Ankle brachial index < 0.9
• Peripheral disease imparts a three to five times higher rate of
cardiovascular ischemic events
• 91.5% of vascular surgery patients have abnormal coronary arteries
• More than 60% have advanced (>70% stenosis) CAD
• 20% PAD patients have >70% carotid artery stenosis
• Claudication usually masks ischemic heart disease (functional decline)
• Primary anesthesia goal is to preserve cardiac and vital organ
function
Risk Factors
• Male
• Older age
• Family history
• Marfan syndrome
• Ehler’s Danlos
• Low high-density lipoproteins
• Smoking (doubles risk and causes progression)
• Diabetes mellitus
• Hypertension
• Obesity
• Dyslipidemia
• Homocysteine, fibrinogen, lipoprotein(a), apolipoproteins B
and A-I, C-reactive protein levels
LesionLocations
• Most commonly from
atherosclerosis in
large to medium
vessels, at sites of
turbulent flow
• Peripheral disease
mirrors that of the
aorta, coronary
arteries, and
extracranial cerebral
arteries.
EndothelialCellInjury
Damage causes monocyte adhesion
InflammatoryCellMigration
Monocytes migrate to the tunica intima, becoming macrophages and engulf lipoproteins (LDL).
T-cells also implicated
LipidsAccumulateandSmoothMuscleProliferates
Macrophages oxidize and phagocytize the LDL , becoming foam cells. They also release growth
factors
PlaqueForms
Fibrofattyplaqueofatherosclerosis
Signs and Symptoms
• Intermittent claudication
• Rest pain
• Nonhealing skin lesions
• Decreases to absent arterial pulses
• Bruits
• Subcutaneous atrophy
• Alopecia
• Coolness
• Pallor
• Cyanosis
• Dependent redness
• Relief from hanging affected extremity dependently
Diagnosis
• Ankle-Brachial Index
• 1.0-1.1: Normal
• <0.9: Intermittent claudication (other texts say < 0.5)
• <0.4: Rest pain
• <0.25: ischemic ulceration & gangrene (other texts say < 0.2)
• Indicates disease proximal to measurement
• Transcutaneous oximetry
• Normal in the resting foot: 60 mm Hg
• <40 mm Hg: ischemic ulceration
• MRI and contrast angiography
• Used to guide surgical intervention
Treatment
• Exercise programs
• Modifying risk factors
• Smoking cessation
• Lipid-lowering therapy
• Glucose control
• Pharmacologic
• Antiplatelet drugs (ASA, clopidogrel)
• Statins
• Lumbar sympathectomy for persistent vasospasm
• Revascularization (Endovascular and Surgical)
• For severe claudication, rest pain, non-healing wound, acute
occlusive event
Treatment (Endovascular)
• Highest success with percutaneous transluminal angioplasty
(PTA) of the iliac arteries
• Femoral & popliteal artery PTA less successful
• Intraarterial thrombolytic therapy
• Balloon catheter embolectomy
• Stents
• Stent placement has improved both approaches
• Restenosis still a large problem
Treatment (Surgical)
• Depends on location and severity
• Endarterectomy
• Bypass grafting
• Saphenous (reversed) > umbilical vein and
polytetrafluoroethylene
• Aortobifemoral bypass for aortoiliac disease
• Aortoiliac reconstruction
• Axillobifemoral bypass (circumvents the abdominal aorta)
• Femorofemoral bypass for unilateral iliac artery disease
• Infrainguinal bypass
• Femoropopliteal
• Tibioperoneal
• Amputation
Anesthesia for PAD (Preop)
• Risk factor modification more important than anesthetic
approach
• Patient’s usually can’t perform ETT, so they receive MPS with
TTE
• May require PCI for ischemic heart disease first (ACC/AHA
guidelines)
• Statin therapy
• β-blocker therapy (but not initiated day of surgery). At least 7-
10 days prior
Anesthesia for PAD (Intraop)
• Principle risk is myocardial ischemia
• “Tight” hemodynamics
• Avoid hypervolemia, tachycardia (HR <85), anemia (HgB >9.0g/dL)
• Virtually all patients require intra-arterial monitoring
• Allen test is pretty much useless
• Radial artery preferred (collateral circulation)
• Regional (neuraxial) vs. general
• Inconclusive as to one benefiting over the other
• GA: Hypercoaguable state, higher cortisol
• RA: attenuates clotting, stress response, better pain control
• Intraoperative heparinization (at least 1 hour after epidural placement)
• Often on clopidogrel
• Delayed 12-24 hours after last dose of LMWH
• Aortoiliac/Aortofemoral surgery
• Infrarenal aortic cross-clamping vs. aortic cross-clamping
• Heparin prior to clamping
• Spinal cord damage unlikely and special monitors not normally used
Anesthesia for PAD (Postop)
• Analgesia
• Anxiety
• ST-segment analysis
• Frequent peripheral pulse checks
• Fluid and electrolyte derangements
• Ready for urgent re-stenosis management
Acute Arterial Occlusion
• Thrombotic
• More common at 6:1
• Embolism
• Atrial fibrillation, AMI >
• Valve lesions, prosthetic
valves, infective
endocarditis, patent
foramen ovale, plaque
rupture, hypercoagulable
disease
• Usually lodge at arterial
bifurcations
• Aortic dissection
• Trauma
• Signs and Symptoms
• Pistol shot
• Pain
• Paresthesia (late)
• Paralysis (late)
• Pulseless (early)
• Pallor/cyanosis (early)
• Treatment
• Surgical embolectomy
• Heparin
• Intraarterial thrombolysis
Raynaud’s Phenomenon
• Episodic vasospastic
ischemia of the digits
followed by vasodilation and
hyperemia
• Women > men
• Associated to cold exposure
& sympathetic activation
(stress)
• Primary: Raynaud’s disease
• Secondary: Scleroderma and
systemic lupus
erythematosus, beta-
blockers, TCA, ergot
alkaloids, amphetamines
implicated
• Diagnosis: history and
physical, with inflammatory
markers sent to diagnose
secondary causes
• Treatment: Protect from
cold, CCB, alpha blockers,
surgical sympathectomy
• Anesthesia: Keep room
warm, NIBP, regional
anesthesia (without
epinephrine)
Peripheral Venous Disease
Conditions
• Superficial
thrombophlebitis
• Deep vein thrombosis
• Chronic venous
insufficiency
Risk Factors
• Virchow’s triad
• Venous stasis
• Surgery
• Trauma
• Immobility
• Pregnancy
• Low cardiac output
• Stroke
• Hypercoagulability
• Surgery
• Estrogen therapy
• Cancer
• ATIII, protein C, protein S deficiency
• Stress
• Inflammatory bowel disease
• Vessel wall abnormality
• Varicose veins
• Drug-induced
• History of thromboembolism
• Morbid obesity
• Advanced age
Venous Thromboembolism
Prevention
• Early ambulation
• Compression stockings
• Procedure < 1 hour
• Subcutaneous heparin 5000
units BID – TID
• Intermittent external
pneumatic compression
devices
• Use of regional anesthesia
• 20-40% reduction after total
hip or knee surgery
(vasodilation)
• Allows for earlier ambulation
(analgesia)
Treatment
• Heparin (LMWH or
unfractionated)
• Warfarin (INR 2-3)
• Inferior vena cava filter
• Thrombophilia workup
• Factor V Leiden
• Antithrombin III deficiency
• Protein C deficiency
• Protein S deficiency
• Plasminogen
• Increased antiphospholipid
antibodies
SYSTEMIC VASCULITIS
Key Points to Vasculitis
• “Angiitis, arteritis”
• Signs/Symptoms: fever, myalgias, arthralgia, malaise
• Understand what vessels are affected
• Large vessels: aorta and main branches
• Medium vessels: coronary arteries
• Small vessels: arterioles, venules, and capillaries. Type III
immune complex reactions. Serum antineutrophil cytoplasmic
antibodies (ANCA) correlate to disease severity.
• Treatments usually include glucocorticoids (adrenal
suppression), underlying pathology, and immunosuppression
agents
Systemic Vasculitis Types
Large Artery
• Takayasu’s arteritis
• Temporal (giant cell)
arteritis
Small & Medium Artery
• Kawasaki’s disease
• Thromboangiitis obliterans
• Wegener’s granulomatosis
• Polyarteritis nodosa
Takayasu’s Arteritis
• Many names
• Pulseless disease
• Occlusive thromboaortopathy
• Aortic arch syndrome
• Large-vessels
• Aorta and it’s branches
• Carotid arteries
• Subclavian arteries
• Pulmonary arteries
• Renal arteries
• Treatment:
• Glucocorticoids
• Methotrexate
• Azathioprine
• Anticoagulants/antiplatelets
• Percutaneous/surgical
intervention
• Anesthesia
• Adrenocortical suppression?
• Head positioning implications on
cerebral function?
• Avoid hyperventilation (cerebral
vasculature already stenotic)
• EEG monitoring?
• NIBP vs. IBP monitoring?
Temporal (Giant Cell) Arteritis
• Head & Neck Large
Arteries
• Ophthalmic artery
• Diagnosis
• Persons >50yo with
unilateral headache,
jaw claudication,
ischmic optic neuritis,
unilateral blindess
• Treatment:
• Glucocorticoids
• Anesthesia…
Kawasaki’s Disease
• “Mucocutaneous lymph
node syndrome”
• Signs and Symptoms
• Children
• Fever
• Conjunctivitis
• Inflamed mucous membranes
(“Strawberry tongue”)
• Swollen hands/feet
• Truncal rash
• Cervical lymphadenopathy
• Medium-sized vessels
• Coronary arteries
• Treatment
• Gamma globulin
• Aspirin
• Anesthesia
• Intraoperative MI
• Sympathectomy potentially
good
Thromboanglitis Obliterans
• “Buerger’s disease”
• Associations
• Men <45 yo
• Tobacco use
• Raynaud’s
• Small-Medium arteries
and veins of the
extremities
• Treatment
• Stop smoking
• No established drug
therapy
• Anesthesia
• Avoid triggers
• Warm room
• Warmed and humidified
gas (maintain body temp)
• Meticulous padding of
pressure points
• NIBP
• Avoid epinephrine if using
regional anesthesia
Wegener’s Granulomatosis
• Necrotizing
gramulomas in vessels
• CNS
• Airways
• Lungs
• Cardiovascular
• Kidneys
• Treatment
• Glucocorticoids
• Methotrexate
• Rituximab
• Maintenance with
azathioprine or
methotrexate
• Anesthesia
• Sinusitis may be present
• Renal failure may be
present
• Laryngeal mucosa
replaced by granulation
tissue (narrowed, stiff)
Churg-Strauss Syndrome
• Small-medium vessels
• Respiratory system
• Rhinitis
• Asthma
• Eosinophilia
• Treatment
• Glucocorticoid
• Immunosuppression
• Anesthesia
• Often come in for nasal
polypectomy &
myringotomy tubes
• Reactive airway
Polyarteritis Nodosa
• Associated
• HIV, HBV, HCV, hairy
cell leukemia
• Males
• Small to medium
vessels
• Treatment
• Glucocorticoids
• Cyclophosphamide
• Treat underlying
disease
• Anesthesia
• Likely renal disease
• Likely cardiac disease
• Systemic hypetension
Key References
1. Hall JE. Guyton and Hall Textbook of Medical Physiology. Elsevier
Health Sciences; 2016.
2. Stoelting RK, Hines RL, Marschall KE. Stoelting's anesthesia and co-
existing disease. 6th ed. Philadelphia: Saunders/Elsevier; 2012.
3. Miller RD. Miller's anesthesia. 8th ed. Philadelphia, PA:
Elsevier/Saunders; 2015.
4. Yao FSF, Fontes ML, Malhotra V. Yao and Artusio’s Anesthesiology:
Problem-Oriented Patient Management. Wolters Kluwer Health;
2012.
5. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional Anesthesia
in the Patient Receiving Antithrombotic or Thrombolytic Therapy:
American Society of Regional Anesthesia and Pain Medicine
Evidence-Based Guidelines (Third Edition). Regional Anesthesia
and Pain Medicine. 2010;35(1):64-101.

More Related Content

What's hot

Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantationSouvik Maitra
 
The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...
The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...
The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...Intensive Care Society
 
HAEMODYNAMIC MONITORING – CVP, PAC AND IBP
HAEMODYNAMIC MONITORING – CVP, PAC AND IBPHAEMODYNAMIC MONITORING – CVP, PAC AND IBP
HAEMODYNAMIC MONITORING – CVP, PAC AND IBPGowri Shankar
 
Statistics for Anaesthesiologists
Statistics for AnaesthesiologistsStatistics for Anaesthesiologists
Statistics for Anaesthesiologistsxeonfusion
 
Cardiac output & monitoring
Cardiac output &  monitoringCardiac output &  monitoring
Cardiac output & monitoringArundev P Nair
 
Scott Weingart - Emergent Intubation Resequenced
Scott Weingart - Emergent Intubation ResequencedScott Weingart - Emergent Intubation Resequenced
Scott Weingart - Emergent Intubation ResequencedSMACC Conference
 
Fluid responsiveness - an ICU phoenix
Fluid responsiveness - an ICU phoenixFluid responsiveness - an ICU phoenix
Fluid responsiveness - an ICU phoenixNIICS
 
ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)Abhay Rajpoot
 
Mechanical Ventilation in Critical Care: Why driving pressure matters
Mechanical Ventilation in Critical Care: Why driving pressure mattersMechanical Ventilation in Critical Care: Why driving pressure matters
Mechanical Ventilation in Critical Care: Why driving pressure mattersSMACC Conference
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageSasidhar Puvvula
 
Identifying Asynchrony and Solving the Problem - Pilbeam
Identifying Asynchrony and Solving the Problem - PilbeamIdentifying Asynchrony and Solving the Problem - Pilbeam
Identifying Asynchrony and Solving the Problem - PilbeamRiver City Symposium
 
Newer modes of ventilation
Newer modes of ventilationNewer modes of ventilation
Newer modes of ventilationRajesh Munigial
 
Anaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseAnaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseDhritiman Chakrabarti
 
Patient ventilator interactions during mechanical ventilation
Patient ventilator interactions during mechanical ventilationPatient ventilator interactions during mechanical ventilation
Patient ventilator interactions during mechanical ventilationDr.Mahmoud Abbas
 

What's hot (20)

Airway ultrasound
Airway ultrasoundAirway ultrasound
Airway ultrasound
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...
The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...
The New 2018 SCCM PADIS Guidelines: Quick Hits of Recommendations for Sedatio...
 
Airway during CPR
Airway during CPRAirway during CPR
Airway during CPR
 
HAEMODYNAMIC MONITORING – CVP, PAC AND IBP
HAEMODYNAMIC MONITORING – CVP, PAC AND IBPHAEMODYNAMIC MONITORING – CVP, PAC AND IBP
HAEMODYNAMIC MONITORING – CVP, PAC AND IBP
 
Perioperative anaphylaxis
Perioperative anaphylaxisPerioperative anaphylaxis
Perioperative anaphylaxis
 
Statistics for Anaesthesiologists
Statistics for AnaesthesiologistsStatistics for Anaesthesiologists
Statistics for Anaesthesiologists
 
Cardiac output & monitoring
Cardiac output &  monitoringCardiac output &  monitoring
Cardiac output & monitoring
 
Picco application note 2 (1)
Picco application note 2 (1)Picco application note 2 (1)
Picco application note 2 (1)
 
Scott Weingart - Emergent Intubation Resequenced
Scott Weingart - Emergent Intubation ResequencedScott Weingart - Emergent Intubation Resequenced
Scott Weingart - Emergent Intubation Resequenced
 
Fluid responsiveness - an ICU phoenix
Fluid responsiveness - an ICU phoenixFluid responsiveness - an ICU phoenix
Fluid responsiveness - an ICU phoenix
 
ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)
 
Mechanical Ventilation in Critical Care: Why driving pressure matters
Mechanical Ventilation in Critical Care: Why driving pressure mattersMechanical Ventilation in Critical Care: Why driving pressure matters
Mechanical Ventilation in Critical Care: Why driving pressure matters
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhage
 
Usg and anaesthesia
Usg and anaesthesiaUsg and anaesthesia
Usg and anaesthesia
 
Identifying Asynchrony and Solving the Problem - Pilbeam
Identifying Asynchrony and Solving the Problem - PilbeamIdentifying Asynchrony and Solving the Problem - Pilbeam
Identifying Asynchrony and Solving the Problem - Pilbeam
 
Newer modes of ventilation
Newer modes of ventilationNewer modes of ventilation
Newer modes of ventilation
 
Picco
PiccoPicco
Picco
 
Anaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseAnaesthesia for congenital heart disease
Anaesthesia for congenital heart disease
 
Patient ventilator interactions during mechanical ventilation
Patient ventilator interactions during mechanical ventilationPatient ventilator interactions during mechanical ventilation
Patient ventilator interactions during mechanical ventilation
 

Viewers also liked (19)

What we know about pain? (A Challenge Phenomena) - A. Husni Tanra
What we know about pain?(A Challenge Phenomena) - A. Husni TanraWhat we know about pain?(A Challenge Phenomena) - A. Husni Tanra
What we know about pain? (A Challenge Phenomena) - A. Husni Tanra
 
Physiologic Changes in Laproscopy
Physiologic Changes in LaproscopyPhysiologic Changes in Laproscopy
Physiologic Changes in Laproscopy
 
Sympathectomy for pheripheral arterial disease present role
Sympathectomy for pheripheral arterial disease present roleSympathectomy for pheripheral arterial disease present role
Sympathectomy for pheripheral arterial disease present role
 
A Dellinger (CV, July 2016)
A Dellinger (CV, July 2016)A Dellinger (CV, July 2016)
A Dellinger (CV, July 2016)
 
VanSavageCV July 2015
VanSavageCV July 2015VanSavageCV July 2015
VanSavageCV July 2015
 
jts-cv-514
jts-cv-514jts-cv-514
jts-cv-514
 
CV 2015
CV  2015CV  2015
CV 2015
 
my cv resume updated PDF sep 2016
my cv resume updated PDF sep  2016my cv resume updated PDF sep  2016
my cv resume updated PDF sep 2016
 
CV 2016
CV 2016CV 2016
CV 2016
 
A case presentation on Peripheral Arterial Occlusive disease
A case presentation on Peripheral Arterial Occlusive diseaseA case presentation on Peripheral Arterial Occlusive disease
A case presentation on Peripheral Arterial Occlusive disease
 
CV JULY 22 2016
CV  JULY 22 2016CV  JULY 22 2016
CV JULY 22 2016
 
Gianoli - CV
Gianoli - CVGianoli - CV
Gianoli - CV
 
Sherif Soliman C.V
Sherif Soliman C.VSherif Soliman C.V
Sherif Soliman C.V
 
updated CV Feb 2015 KSA
updated CV Feb 2015 KSAupdated CV Feb 2015 KSA
updated CV Feb 2015 KSA
 
CV Dennis Fowler July 2014
CV  Dennis Fowler July 2014CV  Dennis Fowler July 2014
CV Dennis Fowler July 2014
 
CV WG MD Apr 2015
CV WG MD Apr 2015CV WG MD Apr 2015
CV WG MD Apr 2015
 
ghio cv lawyers 7 1 2016
ghio cv lawyers 7 1 2016ghio cv lawyers 7 1 2016
ghio cv lawyers 7 1 2016
 
Cervical sympathectomy
Cervical sympathectomyCervical sympathectomy
Cervical sympathectomy
 
Retroperitoneal approach to the lumbar spine1
Retroperitoneal approach to the lumbar spine1Retroperitoneal approach to the lumbar spine1
Retroperitoneal approach to the lumbar spine1
 

Similar to CV-Peripheral Vascular Disease 2

peripherial arterial disease
peripherial arterial diseaseperipherial arterial disease
peripherial arterial diseaseNote Noteenote
 
Topic : Peripheral Vascular Disease.pptx
Topic : Peripheral Vascular Disease.pptxTopic : Peripheral Vascular Disease.pptx
Topic : Peripheral Vascular Disease.pptxzaaprotta
 
Management of peripheral vascular disease by Sunil Kumar Daha
Management of peripheral vascular disease by Sunil Kumar DahaManagement of peripheral vascular disease by Sunil Kumar Daha
Management of peripheral vascular disease by Sunil Kumar Dahasunil kumar daha
 
arterial disease .. December 2019
 arterial disease .. December 2019 arterial disease .. December 2019
arterial disease .. December 2019ghufranhariri1
 
Acute limb ischemia
Acute limb ischemiaAcute limb ischemia
Acute limb ischemiaTapish Sahu
 
Initial Management :- the patient with AHF on the ICU
Initial Management :- the patient with AHF on the ICUInitial Management :- the patient with AHF on the ICU
Initial Management :- the patient with AHF on the ICUdrucsamal
 
Diagnosis and management of Acute limb -ischemia (1).ppt
Diagnosis  and management of  Acute limb -ischemia (1).pptDiagnosis  and management of  Acute limb -ischemia (1).ppt
Diagnosis and management of Acute limb -ischemia (1).pptssuser57f298
 
Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (Natalia Perez de Arriba
 
Acute limb ischemia
Acute limb ischemiaAcute limb ischemia
Acute limb ischemiamanjil malla
 

Similar to CV-Peripheral Vascular Disease 2 (20)

Tutorial ischaemia of lower limbs
Tutorial ischaemia of lower limbsTutorial ischaemia of lower limbs
Tutorial ischaemia of lower limbs
 
peripherial arterial disease
peripherial arterial diseaseperipherial arterial disease
peripherial arterial disease
 
Topic : Peripheral Vascular Disease.pptx
Topic : Peripheral Vascular Disease.pptxTopic : Peripheral Vascular Disease.pptx
Topic : Peripheral Vascular Disease.pptx
 
Cardiac cath complications
Cardiac cath complicationsCardiac cath complications
Cardiac cath complications
 
Management of peripheral vascular disease by Sunil Kumar Daha
Management of peripheral vascular disease by Sunil Kumar DahaManagement of peripheral vascular disease by Sunil Kumar Daha
Management of peripheral vascular disease by Sunil Kumar Daha
 
Arterial Disease
Arterial DiseaseArterial Disease
Arterial Disease
 
arterial disease .. December 2019
 arterial disease .. December 2019 arterial disease .. December 2019
arterial disease .. December 2019
 
Acute limb ischemia
Acute limb ischemiaAcute limb ischemia
Acute limb ischemia
 
Acute myocardial infarction
Acute myocardial infarctionAcute myocardial infarction
Acute myocardial infarction
 
Acute limb ischaemia
Acute limb ischaemiaAcute limb ischaemia
Acute limb ischaemia
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Initial Management :- the patient with AHF on the ICU
Initial Management :- the patient with AHF on the ICUInitial Management :- the patient with AHF on the ICU
Initial Management :- the patient with AHF on the ICU
 
Diagnosis and management of Acute limb -ischemia (1).ppt
Diagnosis  and management of  Acute limb -ischemia (1).pptDiagnosis  and management of  Acute limb -ischemia (1).ppt
Diagnosis and management of Acute limb -ischemia (1).ppt
 
Hocm mpuh
Hocm mpuhHocm mpuh
Hocm mpuh
 
Vasculitis1
Vasculitis1Vasculitis1
Vasculitis1
 
Acute limb ischemia
Acute limb ischemiaAcute limb ischemia
Acute limb ischemia
 
Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (
 
Takayasusarteritis
TakayasusarteritisTakayasusarteritis
Takayasusarteritis
 
Acute limb ischemia
Acute limb ischemiaAcute limb ischemia
Acute limb ischemia
 
TACHY ARRYTHMIAS
TACHY ARRYTHMIASTACHY ARRYTHMIAS
TACHY ARRYTHMIAS
 

CV-Peripheral Vascular Disease 2

  • 1. Anesthesia & Peripheral Vascular Disease Justin Scott Fulkerson ACNP-BC, sRNA
  • 2. Outline • Anatomy Review • Peripheral Arterial Diseases (major) • Peripheral Venous Diseases (secondary) • Systemic Vasculitis (time permitting)
  • 4. QuickReminders • Arteries Large Medium Small • Arterioles Higher muscle ratio and can completely occlude lumen 2/3 of total systemic resistance • Capillaries One-cell thick Highest cross-sectional area Exchange nutrients • Venules Collect blood • Veins Blood reservoir (64%) 8x more distensible Low pressure Thin walls (less muscle)
  • 5. BloodVessels Tunica intima (Endothelium, basement membrane); tunica media; tunica externa
  • 7. Bottom Line Up Front • Also known as peripheral artery disease, peripheral arterial disease, peripheral vascular disease, peripheral arterial insufficiency, chronic arterial insufficiency, PAD, PVD • Miller: Aneurysmal or occlusive arterial disease of the extremities, visceral organs, head, neck, and brain • Defined as compromised blood flow to the extremities • Ankle brachial index < 0.9 • Peripheral disease imparts a three to five times higher rate of cardiovascular ischemic events • 91.5% of vascular surgery patients have abnormal coronary arteries • More than 60% have advanced (>70% stenosis) CAD • 20% PAD patients have >70% carotid artery stenosis • Claudication usually masks ischemic heart disease (functional decline) • Primary anesthesia goal is to preserve cardiac and vital organ function
  • 8. Risk Factors • Male • Older age • Family history • Marfan syndrome • Ehler’s Danlos • Low high-density lipoproteins • Smoking (doubles risk and causes progression) • Diabetes mellitus • Hypertension • Obesity • Dyslipidemia • Homocysteine, fibrinogen, lipoprotein(a), apolipoproteins B and A-I, C-reactive protein levels
  • 9. LesionLocations • Most commonly from atherosclerosis in large to medium vessels, at sites of turbulent flow • Peripheral disease mirrors that of the aorta, coronary arteries, and extracranial cerebral arteries.
  • 11. InflammatoryCellMigration Monocytes migrate to the tunica intima, becoming macrophages and engulf lipoproteins (LDL). T-cells also implicated
  • 12. LipidsAccumulateandSmoothMuscleProliferates Macrophages oxidize and phagocytize the LDL , becoming foam cells. They also release growth factors
  • 15. Signs and Symptoms • Intermittent claudication • Rest pain • Nonhealing skin lesions • Decreases to absent arterial pulses • Bruits • Subcutaneous atrophy • Alopecia • Coolness • Pallor • Cyanosis • Dependent redness • Relief from hanging affected extremity dependently
  • 16. Diagnosis • Ankle-Brachial Index • 1.0-1.1: Normal • <0.9: Intermittent claudication (other texts say < 0.5) • <0.4: Rest pain • <0.25: ischemic ulceration & gangrene (other texts say < 0.2) • Indicates disease proximal to measurement • Transcutaneous oximetry • Normal in the resting foot: 60 mm Hg • <40 mm Hg: ischemic ulceration • MRI and contrast angiography • Used to guide surgical intervention
  • 17. Treatment • Exercise programs • Modifying risk factors • Smoking cessation • Lipid-lowering therapy • Glucose control • Pharmacologic • Antiplatelet drugs (ASA, clopidogrel) • Statins • Lumbar sympathectomy for persistent vasospasm • Revascularization (Endovascular and Surgical) • For severe claudication, rest pain, non-healing wound, acute occlusive event
  • 18. Treatment (Endovascular) • Highest success with percutaneous transluminal angioplasty (PTA) of the iliac arteries • Femoral & popliteal artery PTA less successful • Intraarterial thrombolytic therapy • Balloon catheter embolectomy • Stents • Stent placement has improved both approaches • Restenosis still a large problem
  • 19. Treatment (Surgical) • Depends on location and severity • Endarterectomy • Bypass grafting • Saphenous (reversed) > umbilical vein and polytetrafluoroethylene • Aortobifemoral bypass for aortoiliac disease • Aortoiliac reconstruction • Axillobifemoral bypass (circumvents the abdominal aorta) • Femorofemoral bypass for unilateral iliac artery disease • Infrainguinal bypass • Femoropopliteal • Tibioperoneal • Amputation
  • 20. Anesthesia for PAD (Preop) • Risk factor modification more important than anesthetic approach • Patient’s usually can’t perform ETT, so they receive MPS with TTE • May require PCI for ischemic heart disease first (ACC/AHA guidelines) • Statin therapy • β-blocker therapy (but not initiated day of surgery). At least 7- 10 days prior
  • 21. Anesthesia for PAD (Intraop) • Principle risk is myocardial ischemia • “Tight” hemodynamics • Avoid hypervolemia, tachycardia (HR <85), anemia (HgB >9.0g/dL) • Virtually all patients require intra-arterial monitoring • Allen test is pretty much useless • Radial artery preferred (collateral circulation) • Regional (neuraxial) vs. general • Inconclusive as to one benefiting over the other • GA: Hypercoaguable state, higher cortisol • RA: attenuates clotting, stress response, better pain control • Intraoperative heparinization (at least 1 hour after epidural placement) • Often on clopidogrel • Delayed 12-24 hours after last dose of LMWH • Aortoiliac/Aortofemoral surgery • Infrarenal aortic cross-clamping vs. aortic cross-clamping • Heparin prior to clamping • Spinal cord damage unlikely and special monitors not normally used
  • 22. Anesthesia for PAD (Postop) • Analgesia • Anxiety • ST-segment analysis • Frequent peripheral pulse checks • Fluid and electrolyte derangements • Ready for urgent re-stenosis management
  • 23. Acute Arterial Occlusion • Thrombotic • More common at 6:1 • Embolism • Atrial fibrillation, AMI > • Valve lesions, prosthetic valves, infective endocarditis, patent foramen ovale, plaque rupture, hypercoagulable disease • Usually lodge at arterial bifurcations • Aortic dissection • Trauma • Signs and Symptoms • Pistol shot • Pain • Paresthesia (late) • Paralysis (late) • Pulseless (early) • Pallor/cyanosis (early) • Treatment • Surgical embolectomy • Heparin • Intraarterial thrombolysis
  • 24. Raynaud’s Phenomenon • Episodic vasospastic ischemia of the digits followed by vasodilation and hyperemia • Women > men • Associated to cold exposure & sympathetic activation (stress) • Primary: Raynaud’s disease • Secondary: Scleroderma and systemic lupus erythematosus, beta- blockers, TCA, ergot alkaloids, amphetamines implicated • Diagnosis: history and physical, with inflammatory markers sent to diagnose secondary causes • Treatment: Protect from cold, CCB, alpha blockers, surgical sympathectomy • Anesthesia: Keep room warm, NIBP, regional anesthesia (without epinephrine)
  • 25. Peripheral Venous Disease Conditions • Superficial thrombophlebitis • Deep vein thrombosis • Chronic venous insufficiency Risk Factors • Virchow’s triad • Venous stasis • Surgery • Trauma • Immobility • Pregnancy • Low cardiac output • Stroke • Hypercoagulability • Surgery • Estrogen therapy • Cancer • ATIII, protein C, protein S deficiency • Stress • Inflammatory bowel disease • Vessel wall abnormality • Varicose veins • Drug-induced • History of thromboembolism • Morbid obesity • Advanced age
  • 26. Venous Thromboembolism Prevention • Early ambulation • Compression stockings • Procedure < 1 hour • Subcutaneous heparin 5000 units BID – TID • Intermittent external pneumatic compression devices • Use of regional anesthesia • 20-40% reduction after total hip or knee surgery (vasodilation) • Allows for earlier ambulation (analgesia) Treatment • Heparin (LMWH or unfractionated) • Warfarin (INR 2-3) • Inferior vena cava filter • Thrombophilia workup • Factor V Leiden • Antithrombin III deficiency • Protein C deficiency • Protein S deficiency • Plasminogen • Increased antiphospholipid antibodies
  • 28. Key Points to Vasculitis • “Angiitis, arteritis” • Signs/Symptoms: fever, myalgias, arthralgia, malaise • Understand what vessels are affected • Large vessels: aorta and main branches • Medium vessels: coronary arteries • Small vessels: arterioles, venules, and capillaries. Type III immune complex reactions. Serum antineutrophil cytoplasmic antibodies (ANCA) correlate to disease severity. • Treatments usually include glucocorticoids (adrenal suppression), underlying pathology, and immunosuppression agents
  • 29. Systemic Vasculitis Types Large Artery • Takayasu’s arteritis • Temporal (giant cell) arteritis Small & Medium Artery • Kawasaki’s disease • Thromboangiitis obliterans • Wegener’s granulomatosis • Polyarteritis nodosa
  • 30. Takayasu’s Arteritis • Many names • Pulseless disease • Occlusive thromboaortopathy • Aortic arch syndrome • Large-vessels • Aorta and it’s branches • Carotid arteries • Subclavian arteries • Pulmonary arteries • Renal arteries • Treatment: • Glucocorticoids • Methotrexate • Azathioprine • Anticoagulants/antiplatelets • Percutaneous/surgical intervention • Anesthesia • Adrenocortical suppression? • Head positioning implications on cerebral function? • Avoid hyperventilation (cerebral vasculature already stenotic) • EEG monitoring? • NIBP vs. IBP monitoring?
  • 31. Temporal (Giant Cell) Arteritis • Head & Neck Large Arteries • Ophthalmic artery • Diagnosis • Persons >50yo with unilateral headache, jaw claudication, ischmic optic neuritis, unilateral blindess • Treatment: • Glucocorticoids • Anesthesia…
  • 32. Kawasaki’s Disease • “Mucocutaneous lymph node syndrome” • Signs and Symptoms • Children • Fever • Conjunctivitis • Inflamed mucous membranes (“Strawberry tongue”) • Swollen hands/feet • Truncal rash • Cervical lymphadenopathy • Medium-sized vessels • Coronary arteries • Treatment • Gamma globulin • Aspirin • Anesthesia • Intraoperative MI • Sympathectomy potentially good
  • 33. Thromboanglitis Obliterans • “Buerger’s disease” • Associations • Men <45 yo • Tobacco use • Raynaud’s • Small-Medium arteries and veins of the extremities • Treatment • Stop smoking • No established drug therapy • Anesthesia • Avoid triggers • Warm room • Warmed and humidified gas (maintain body temp) • Meticulous padding of pressure points • NIBP • Avoid epinephrine if using regional anesthesia
  • 34. Wegener’s Granulomatosis • Necrotizing gramulomas in vessels • CNS • Airways • Lungs • Cardiovascular • Kidneys • Treatment • Glucocorticoids • Methotrexate • Rituximab • Maintenance with azathioprine or methotrexate • Anesthesia • Sinusitis may be present • Renal failure may be present • Laryngeal mucosa replaced by granulation tissue (narrowed, stiff)
  • 35. Churg-Strauss Syndrome • Small-medium vessels • Respiratory system • Rhinitis • Asthma • Eosinophilia • Treatment • Glucocorticoid • Immunosuppression • Anesthesia • Often come in for nasal polypectomy & myringotomy tubes • Reactive airway
  • 36. Polyarteritis Nodosa • Associated • HIV, HBV, HCV, hairy cell leukemia • Males • Small to medium vessels • Treatment • Glucocorticoids • Cyclophosphamide • Treat underlying disease • Anesthesia • Likely renal disease • Likely cardiac disease • Systemic hypetension
  • 37. Key References 1. Hall JE. Guyton and Hall Textbook of Medical Physiology. Elsevier Health Sciences; 2016. 2. Stoelting RK, Hines RL, Marschall KE. Stoelting's anesthesia and co- existing disease. 6th ed. Philadelphia: Saunders/Elsevier; 2012. 3. Miller RD. Miller's anesthesia. 8th ed. Philadelphia, PA: Elsevier/Saunders; 2015. 4. Yao FSF, Fontes ML, Malhotra V. Yao and Artusio’s Anesthesiology: Problem-Oriented Patient Management. Wolters Kluwer Health; 2012. 5. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Regional Anesthesia and Pain Medicine. 2010;35(1):64-101.

Editor's Notes

  1. Figure 14-1: Hall JE. Guyton and Hall Textbook of Medical Physiology. 13th ed. Elsevier Health Sciences; 2015. https://books.google.com/books?id=krLSCQAAQBAJ. Arteries are classified as large, medium, and small based on compliance. Arterioles are the site of highest systemic vascular resistance (remember in the large cross-sectional anatomy that in parallel, we can change the circuit’s resistance). Capillaries are where nutrient exchange occurs, and are only one cell thick without musculature. Venules receive blood from the capillaries and feed to the blood reserviour – the veins. Veins are more highly distensible, and the peripheral veins have valves (whereas the larger abdominal and thoracic veins do not).
  2. FIGURE 30.2 • Blood vessels—microanatomy of the artery, vein, and capillary beds. (From McConnell T. H., Hull K. L. (2011). Human form human function: Essentials of anatomy & physiology (p. 433, Figure 11–12). Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins.) All vessels are three layers, except capillaries. Endothelial cells form a continuous lining – the endothelium. It regulates molecule transfer, platelet adhesion, modulation of blood flow, metabolism of hormones, regulation of immune and inflammatory reactions, and produce nitric oxide and endothelins. The endothelium is a huge site of interest as a biologically active tissue. Tunica media is smooth muscle interconnected with gap junctions. Norepinephrine is released from sympathetic nerves regulating tone here (remember the SVR). Blood flow is regulated by myogenic means, production of local metabolites, and can auto-regulate between 70 – 175 mm Hg (systemic vasculature). External regulation occurs from sympathetic tone (and occasionally parasympathetic producing Nitric Oxide, as in the case of the naught—bits), and hormones.
  3. Just a quick reminder of a few last physiology concepts: Poiseulle’s law tells use flow is fastest away from vessel lumens. As diameter changes in vessels, the conductance is altered by a fourth power. Figure 14-8: Hall JE. Guyton and Hall Textbook of Medical Physiology. 13th ed. Elsevier Health Sciences; 2015. https://books.google.com/books?id=krLSCQAAQBAJ.
  4. Peripheral arterial disease is known by many names, as listed. By definition, PAD is an ankle brachial index < 0.9 (this correlates very well to angiographic-evidenced PAD). The major concern is perioperative cardiac events more than developing critical limb ischemia, as evidenced by the 91.5% association with abnormal coronary arteries. Our primary goal is preserve cardiac and vital organ perfusion. 1 Stoelting RK, Hines RL, Marschall KE. Stoelting’s Anesthesia and Co-Existing Disease. Vol 6. Saunders/Elsevier; 2012. https://books.google.com/books?id=LXPBrqZAIiEC.
  5. Occurs in 70% of persons over 75 years old. I bolded the modifiable risk factors (hence, the ones we can “optimize” the patient prior to surery). Claudication and PVD risk is doubled in smokers with higher rates of disease progression (leading to amputation)
  6. Notice that the disease primarily occurs at bifurcations. The most common sites are the aortoiliac vessels, with a close second at the coronaries. The key point is that peripheral vessels mirror central vessels.
  7. And with mono
  8. The “fatty streak” begins in childhood
  9. FIGURE 30.8 • Fibrofatty plaque of atherosclerosis. (A) In this fully developed fibrous plaque, the core contains lipid-filled macrophages and necrotic smooth muscle cell (SMC) debris. The “fibrous” cap is composed largely of SMCs, which produce collagen, small amounts of elastin, and glycosaminoglycans. Also shown are infiltrating macrophages and lymphocytes. Note that the endothelium over the surface of the fibrous cap frequently appears intact. (B) The aorta shows discrete raised, tan plaques. Focal plaque ulcerations are also evident. (From Rubin R., Strayer D. (Eds.). (2012). Rubin’s pathology: Clinicopathologic foundations of medicine (6th ed., p. 447–448). Philadelphia, PA: Lippincott Williams & Wilkins.) Type
  10. Intermittent claudication occurs when metabolic demand exceeds oxygen delivery Rest pain occurs without exertion. Usually the first sign is decrease peripheral pulses Bruits can indicate the site of the lesion. Hanging the extremity increase hydrostatic pressure in the arterioles, facilitating better oxygen delivery
  11. Beta blockers have been theorized to evoke peripheral cutaneous vascoconstriction, but RCTs have failed to bear this out.
  12. Regional: can reduce change of postoperative delirium, allows for patient to communicate myocardial ischemia symptoms, less activation of the coagulation system, fewer post operative pulmonary complications Intraoperative heparinization is not a contraindication. Surgical team should be aware that if a blood tap occurs, procedure may need to be delayed General anesthesia: for longer procedures, vein harvesting from upper extremities. Cardiac preconditioning from inhaled agetns? Infrarenal aortic cross-clamping associated with fewer hemodynamic changes than aortic cross clamping (same for unclamping).
  13. Occlusion of subclavian or innominate artery proximal to vertebral artery origin. The occlusion causes a reversal of flow through the ipsilateral vertebral artery into the distal subclavian artery. Diverts blood from the brain to the arm. Signs and symptoms are CNS ischemia and ipsilateral arm ischemia. Extremes of neck movements and exercise and produce symptoms. Pulses can be absent or diminished in the affected arm with SBP 20 mm Hg lower in that arm (like coarctation of the aorta). Bruit over the subclavian artery
  14. Occurs with proximal stenosis of the left subclaviarn artery causing reversed blood flow through a patent internal mammary artery graft. Signs and symptoms are angina pectoris and 20 mm Hg or more decrease in systolic BP in the ipsilateral arm.
  15. Surgical embolectomy is used for large vessel occlusion that are not atheromatous. Atheromas fragment with manipulation.
  16. Superficial thrombophlebitis: palpable cord-like veins, localized swelling and pain. DVT: generalized pain, unilateral limb swelling. Compression ultrasonography highly sensitive for proximal thrombus but less for calf thrombus. Can also consider venography
  17. Takayasu’s is rare, idiopathic, chronic, progressive occlusive vasculitis that causes narrowing, thrombossis, or large vessel (aorta) anuerysms. Mostly in Asian women < 40 years old.
  18. Takayasu’s is rare, idiopathic, chronic, progressive occlusive vasculitis that causes narrowing, thrombossis, or large vessel (aorta) anuerysms. Mostly in Asian women < 40 years old.